TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Volume of Desflurane used to maintain BIS 40-60
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: 90-day morbidity and mortality
Endpoint domain: Mortality/survival
Primary endpoint: Acquired tick resistance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline in PET Activation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Liver frailty index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevalence of Erythropoiesis stimulating agents hyporesponsiveness
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: 28 day status alive or dead
Endpoint domain: Mortality/survival
Primary endpoint: Plasma concentrations of bimatoprost and bimatoprost free acid
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ocular and systemic adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Roland Morris Disability Questionnaire Scoring
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Short-Form Health Survey-36
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Tampa Scale Of Kinesiophobia
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Durable Overall Response Rate (DOR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Presence of diagnostic biomarkers
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Biomarkers of severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in the number of clinical biopsies with evidence of gastric intestinal metaplasia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Changes in blood flow to the eye
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Number of Days Homeless
Endpoint domain: Resource use
Endpoint subdomain: Societal/carer burden
Primary endpoint: Peak Cardiorespiratory Fitness
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Stoma Care Knowledge
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Amino acid uptake kinetics
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: percentage of participants reporting immediate AE within 30 minutes of vaccination
Endpoint domain: Adverse events/effects
Primary endpoint: percentage of participants reporting solicited local adverse events (AEs) within 7 days of vaccination
Endpoint domain: Adverse events/effects
Primary endpoint: percentage of participants reporting solicited systemic AEs within 7 days following study vaccination
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Participants With Change from Baseline in Vital Signs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants With Change From Baseline in Suicide Risk Measured by Columbia Suicide Severity Rating Scale [C-SSRS] Child Version
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Fluorescence intensity measurements of tumor tissue
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Normative mucosal integrity values
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Normative pyloric FLIP values
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Change in stocking of healthy and unhealthy foods
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Change in sales of healthy and unhealthy foods
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Hamstrings and low back flexibility
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Single limb stance excursion distances
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Abdomen Core Strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Blood Plasma RNA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Gastric mucosal histology improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Change from Baseline in the Mean 24h Systolic Blood Pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Patient and family centeredness of care
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Degree of improvement
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Proportion of subjects being HBsAg negative at treatment week 12
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Feasibility of study completion
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Response rate of BCMA targeted prime CAR-T treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CPR Event Rate
Endpoint domain: Mortality/survival
Primary endpoint: Normative brain volume curves
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: amount of REM sleep
Endpoint domain: Physiological/clinical
Endpoint subdomain: Sleep
Primary endpoint: Dental Plaque Removal Efficacy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: complete remission or partial remission at 24 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Dermal safety and tolerability assessments
Endpoint domain: Adverse events/effects
Primary endpoint: Frequency of adverse events and serious adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Urine-based 6-sulfatoxymelatonin (6-SMT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Structured Interview Guide for the Hamilton Rating Depression Scale with Atypical Depression Supplement (SIGH-ADS)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Sleep Quality Rating (SQR)
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Objective Measures of Sleep
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Objective Measures of Physical Activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Effect on constipation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Number of participants with arch or CoA repair
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Change in Atrial Fibrillation (AF) Burden
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Regional Cerebral Oxygenation/Blood Flow
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: DAYC-2 Standard Scores of the Communication Domain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fugl Meyer Lower Extremity Motor Subscale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Preparation for future care needs
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Incidence of acute chest pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Clinical Status Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in oxidants
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in antioxidants
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in oxidative DNA damage
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of treatment-emergent adverse events (TEAEs) leading to discontinuation of investigational medicinal product (IMP)
Endpoint domain: Adverse events/effects
Primary endpoint: Cycloplegic Autorefraction (SER)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: participant retention rates
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: impact on knowledge and behavior
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: acceptability of AI-powered chatbot interactions
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: changes in eGFR
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: urine protein to urine creatinine ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: First-time venipuncture success rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of proximally migrated pancreatic stents
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Success rate of endoscopic removal of migrated pancreatic stents
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Carotid Doppler scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change of Integrated gastric acidity (%)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: lean mass measured by dual-energy X-ray absorptiometry
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: lean mass measured by ultrasound
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Median Time from tissue collection to issued treatment plan
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Human Neutrophil gelatinase-associated lipocalin (NGAL)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: proportion and type of somatic disorders
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: prevalence of smoking
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Emotional Vocabulary
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Emotion Comprehension
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Number Of Nocturnal Awakenings
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Average time spent walking per day
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Self-reported drug effects
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Diagnostic accuracy of the NG DetecTool device
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Consistency of drug sensitivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in level of ehealth literacy
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Cerebrospinal fluid levels of immune cells, inflammatory cytokines, immunoglobulins and cell adhesion molecules
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Prevalence of mutations, copy number abnormalities and structural variants
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Quantification and qualification of lesions acquired at the time of HT
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Prevalence of clonal relationship between SMZL and HT
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Comfort of bracing condition - treadmill activity
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Movement ability - treadmill activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ankle stability - treadmill activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in left ventricular diameter
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Number of Participants with T1 PDAC
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Number of Participants with no clear pancreas lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Concentration of DWP212525 and metabolite M16
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in mean postpartum systolic blood pressure (SBP) at 6 weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Depression severity at 3 months postpartum assessed using the Edinburgh Postnatal Depression Scale (EPDS)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Volumetric change of soft palate airway size
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in wound dimensions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: miR-326 expression level quantification
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MEFV expression level quantification
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Semen Volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total sperm Count
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in hsCRP level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Beck Depression Inventory - 2
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Patient Recovery Time
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: All-cause death or rehospitalization for worsening heart failure
Endpoint domain: Mortality/survival
Primary endpoint: Percentage of participants experiencing Treatment Emergent Adverse Events (TEAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of participants experiencing Adverse Events of Special Interest (AESIs)
Endpoint domain: Adverse events/effects
Primary endpoint: Atrial fibrillation related quality of life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Atrial fibrillation related symptom burden
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Preoperative Intrusive Thoughts Inventory (PITI)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Overall satisfaction with the intervention among participants
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Proportion of sessions meeting fidelity threshold
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: change in pediatric respiratory assessment measure (PRAM) score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Detection rate of patients with HCC
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: False referral rate of patients with HCC
Endpoint domain: Adverse events/effects
Primary endpoint: Need for supplementary radiologic liver examination
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: MASH resolution without worsening of liver fibrosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Liver outcomes
Primary endpoint: Cortical voxel activity from source reconstruction analysis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Proportion of specimens yielding scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of neutralizing antibodies against Spike protein
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Synthetic morbidity index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Average attendance rate over 24 months
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Prevalence of Single and Co-infections
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Change in physical, emotional, and sexual violence
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in cyber sexual harassment
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Increased self-efficacy to respond to violence
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Dermatology Quality of life index
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Sense of Identity in patients with Borderline Personality Disorder
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Sense of Identity in healthy controls
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Number of persons complaining of suspected symptoms
Endpoint domain: Adverse events/effects
Primary endpoint: 1.5-year disease-free survival
Endpoint domain: Mortality/survival
Primary endpoint: Cognitive test - MoCA
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: NoL variation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Amplitude of low-frequency fluctuation value
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Northwick Park Questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Proportion of clinically significant cancers detected
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Clinician Experience with Nasopharyngoscopic Velopharyngeal Evaluation
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Identification of pathogenic gene variants
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Individualized treatment adaptations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in GFAP
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Sensitivity of [68Ga]Ga-PentixaFor-PET to detect MM lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Skeletal muscle fiber typing
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Skeletal muscle nuclei
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Mitochondrial morphology
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: EuroQoL-5 Dimension Questionnaire (EQ-5D)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Visual Analogue Scale for Health (VAS)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Acceptance of invasive neuromodulation treatments
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Accuracy of custom-made plate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Quality of Work Life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Temporal patterns of urinary biomarkers
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement of Intestinal Inflammation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Respiratory Muscle strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: UDFF values
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: superiority of [18F]AlF-FAPI-74 PET/CT over [18F]FDG PET/CT
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: superiority of [18F]AlF-FAPI-74 PET/CT over conventional imaging
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: contribution of [18F]AlF-FAPI-74 PET/CT in clinically challenging situations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Number of participants who complete Cogmed training
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Number of participants who attend a Cogmed Kickoff social event
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Number of participants who participate in memory strategy training
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Incidence of Adverse Events and Adverse Device Effects
Endpoint domain: Adverse events/effects
Primary endpoint: Amount of insulin required
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Change in Brief Fatigue Inventory (BFI) Global Score
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Area under the plasma concentration versus time curve (AUC) 0-inf (Metformin only)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Amputation Arm Outcome
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Remission rate of acneiform eruption
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: 30-Day Mortality Count
Endpoint domain: Mortality/survival
Primary endpoint: 90-Day Mortality Count
Endpoint domain: Mortality/survival
Primary endpoint: Number of Grade 3 Adverse Events
Endpoint domain: Adverse events/effects
Primary endpoint: Number of mortalities among AMI patients
Endpoint domain: Mortality/survival